Perceptions held by Investigators, IRB Members and IRB Administrators on the Bioethical Oversight System of National R&D Projects |
Kang, Young Hee
(Department of Pharmacy, Eulji University Hospital)
Lee, Sang Mi (Department of Pharmacy, Eulji University Hospital) Kwon, Kwang Il (College of Pharmacy, Chungnam National University) Kim, Eun Young (College of Pharmacy, Chung-Ang University) Huh, Woo Sung (Department of Nephrology, Samsung Medical Center, Sungkyukwan University School of Medicine) |
1 | Kim OJ, Park BJ, Sohn DR, et al. Current status of the institutional review boards in Korea: constitution, operation, and policy for protection of human research participants. JKMS 2003; 18(1): 3-10. |
2 | Kim SJ. A Study on the Accreditation of Institutional Review Board in the United States: focused on the Association for the Accreditation of Human Research Protection Programs (AAHRPP). Bioethics Policy Studies 2007; 1(2): 157-81. |
3 | Larson E, Bratts T, Zwanziger J, et al. A survey of IRB process in 68 US hospitals. J Nurs Scholarsh 2004; 36(3): 260-4. DOI ScienceOn |
4 | Mansbach J, Acholonu U, Clark S, et al. Variation in institutional review board responses to a standard, observational, pediatric research protocol. Acad Emerg Med 2007; 14(4): 377-80. DOI ScienceOn |
5 | Choe BI. Progress and assessment analysis of the human research protection program in Korea: IRB assessment by the Korean Association of institutional review boards (KAIRB). Ph.D. Dissertation for Bioethics. The Graduate school the Catholic University. 2011 |
6 | Lee JS, Kim OJ, Kim SY, et al. Current Status and Problems of Institutional Review Boards in Korea. Korean J Med Ethics Educ 2006; 9(2): 203-22. |
7 | Lee MS. Problems in the adverse event report procedure and its management. Bioethics Policy Studies 2010; 4(2): 77-97. |
8 | Baik SJ, Kwon I. A Study on Improving Institutional Bioethics Review Board by Comparison of Institutional Review Board. Bioethics Policy Studies 2007; 1(2): 141-56. |
9 | Kim BS. The Study to find the Operation Statuses and Improvement Points of IRB in Korea. Bioethics Policy Studies 2008; 2(3): 291-302. |
10 | Lee JS. The experience of IRB accreditation in Korea. In: The Korean Association of Institutional Review Boards 11th Annual Meeting, Seoul, Korea, September 13, 2013. |
11 | NIH guide: Revised policy for IRB review of human subject protocols in grant applications. National Institutes of Health. Available at: http://grants2.nih.gov/grants/guide/notice-files/NOT-OD-00-031.html (Accessed August 12, 2013). |
12 | Role of Accreditation, AAHRPP. Available at: http:// aahrpp.org/learn/for-research-participants/role-of-accreditation (Accessed October 19, 2013). |
13 | NIH policy: FAQs Human Subjects Research - Requirement for Education. National Institutes of Health. Available at: http://grants.nih.gov/grants/policy/hs_educ_faq.htm (Accessed August 11, 2013). |
14 | Enforcement Decree of Bioethics and Safety Act (President Decree No. 24454). Enforcement Date May 23. 2013 |
15 | NIH guide: Required education in the protection of human research participants. National Institutes of Health. Available at: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-00-039.htm (Accessed August 11, 2013). |
16 | Sugarman J. The role of institutional support in protecting human research subjects. Acad Med 2000; 75(7): 687-92. DOI |
17 | Son YS. Bioethics from the standpoint of Medicine. J Korean Bioethics Assoc 2010; 11(2): 77-84. |
18 | Steinbrook R. Protecting research subjects: the crisis at Johns Hopkins. N Engl J Med 2002; 346(9): 716-20. DOI ScienceOn |
19 | Emanuel EJ, Wood A, Fleischman A, et al. Oversight of human participants research: identifying problems to evaluate reform proposals. Ann Intern Med 2004; 141(4): 282-91. DOI ScienceOn |
20 | National Bioethics Committee. The National Bioethics Committee's report on bioethical problems in Hwang Woo-Suk research. 1st ed. Seoul: Bioethics Policy Resarch Center, 2006: 1-9. |
21 | Key biotechnology indicators. Organization for Economic Cooperation and Development. Available at: http://www.oecd. org/health/biotech/keybiotechnologyindicators.htm (Accessed June 30, 2013). |
22 | Hong SY. A Critical Review on the 'Bioethics & Biosafety Law'. J Korean Bioethics Assoc 2004; 5(1): 13-23. |
23 | Bioethics and Safety Act (Act No. 11690). Enforcement Date May 23, 2013. |
24 | Enforcement Rule of Bioethics and Safety Act (No. 180). Enforcement Date January 2, 2013. |
25 | McWilliams R, Hoover-Fong J, Hamosh A, et al. Problematic variation in local institutional review of a multicenter genetic epidemiology study. JAMA 2003; 290(3): 360-6. DOI ScienceOn |